399 results on '"Yagoda A"'
Search Results
2. Matrix metalloproteinases and morphological features in chronic liver diseases
3. Preliminary results from a Phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia
4. Nonverbal synchrony in diagnostic interviews of individuals with social anxiety disorder
5. Phenotype features of young patients with arterial hypertension and additional renal arteries
6. O013 Preliminary Results from a Phase 1 Study of ALKS 2680, an Orexin-2 receptor Agonist, in Healthy Participants and Patients with Narcolepsy or Idiopathic Hypersomnia
7. Pride in Social Anxiety Disorder
8. Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness
9. Engineering-oriented ground-motion model for Israel
10. A clinical case of microscopic polyarteritis complicated by aseptic thrombendocarditis with aortic valve lesion
11. Matrix metalloproteinases system in the chronic liver diseases
12. Patient Stratification Scale for Population Care Management Strategy
13. The case of cardiac rupture and the development of a false left ventricular aneurysm in a patient with myocardial infarction
14. Vitamin D as a marker of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
15. Matrix metalloproteinases: the role in evolution of liver diseases
16. Complications of liver cirrhosis and matrix metalloproteinases: clinical relationships
17. The role of models as a decision-making support tool rather than a guiding light in managing the COVID-19 pandemic
18. Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study
19. Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients
20. Engineering-Oriented Ground-Motion Model for Israel
21. The possibilities of soluble selectins in the prediction of severe fi brosis in nonalcoholic fatty liver disease
22. Mechanism-Based Approach to New Antibiotic Producers Screening among Actinomycetes in the Course of the Citizen Science Project
23. Mechanism-based Approach to New Antibiotic Producers Screening among Actinomycetes in the Course of Civil Science
24. CO122 Patient Versus Caregiver and Clinician Reports of Cognitive Difficulties in Patients with Schizophrenia Switching to Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: A Post Hoc Analysis
25. Telehealth Visits After Shoulder Surgery: Higher Patient Satisfaction and Lower Costs
26. Automated segmentation of pediatric brain tumors based on multi-parametric MRI and deep learning
27. A Structured Benefit-Risk Assessment to Evaluate a Combination of Olanzapine and Samidorphan for the Treatment of Schizophrenia and Bipolar I Disorder
28. Relationship Between Disorders of Lipid Profile and Features of Liver Cirrhosis- An Open Prospective and Comparative Analysis of Patients of Stavropol Territory in Russian Federation
29. Dynamics of soluble selectins during of therapy of non-alcoholic fatty liver disease
30. “Environmental Agenda” in the latest political history of Republic of North Macedonia (1990s – 2020s)
31. All by myself: Loneliness in social anxiety disorder.
32. Handwriting Kinematics in Patients with Schizophrenia Treated with Long-Acting Injectable Atypical Antipsychotics: Results From the ALPINE Study
33. Influence of proatherogenic factors and genetic thrombophilia on severity of coronary lesion in young patients with myocardial infarction type 1
34. Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study
35. The Medium is the Message: Effects of Mediums of Communication on Perceptions and Emotions in Social Anxiety Disorder
36. The grass is always greener: Envy in social anxiety disorder
37. A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension
38. A Suite of Alternative Ground-Motion Models (GMMs) for Israel
39. A Ground-Motion Database for Israel with Its Corresponding Point-Source Parameters, for Engineering Seismology Applications
40. Long-Term Weight and Metabolic Effects of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies
41. Long-Term Antipsychotic Efficacy of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies
42. Reduced Risk Across Multiple Cardiometabolic Risk Factors With OLZ/SAM Compared With Olanzapine: Results From a 24-Week Phase 3 Study
43. Single Site performance of AI software for stroke detection and Triage
44. Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes
45. Intensive Care Unit Organization, Management, and Value
46. Contributors
47. Don Khan and Truck‐Driving Wives: Dylan’s Fluctuating Lyrics
48. Walter Bernstein’s
49. Walter Bernstein’s Keep Your Head Down
50. Changes in the activity levels and financing sources of Israel’s private for-profit hospitals in the wake of reforms to the public-private divide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.